Varenicline for nicotine cessation in youth: A meta-analysis of randomized controlled trials addressing FDA labeling gaps in age and product use.

J Subst Use Addict TreatApr 25, 2026 (epub)
Clinical ResearchPsychiatryPediatrics

Joo Young Park, Seong-Joon Koh

✦ AI-curated · Sources linked

In 30 seconds

This meta-analysis evaluated the effectiveness and safety of varenicline for nicotine cessation in young adults aged 12 to 26 years, analyzing data from five randomized controlled trials. The study found a statistically significant increase in smoking abstinence rates with varenicline compared to alternative interventions, with a relative risk of 1.99 (95% CI, 1.04-3.80).

Key findings

  • Varenicline significantly increased abstinence rates compared to alternative interventions (RR, 1.99; 95% CI, 1.04-3.80).
  • Abstinence rates with varenicline were also significantly higher compared to placebo (OR, 2.93; 95% CI, 1.01-8.49).
  • Safety profile of varenicline was comparable to placebo regarding treatment-emergent adverse events.

Why it matters

Understanding the effectiveness of varenicline in young adults is crucial as smoking cessation in this population can significantly reduce long-term health risks associated with nicotine use. This evidence may guide clinicians in making informed decisions about cessation strategies.

Source

Published in J Subst Use Addict Treat. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.